2002
DOI: 10.1002/1439-7633(20020902)3:9<897::aid-cbic897>3.0.co;2-b
|View full text |Cite
|
Sign up to set email alerts
|

Purine-Based Inhibitors of Inositol-1,4,5-trisphosphate-3-kinase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
39
0

Year Published

2002
2002
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 68 publications
(44 citation statements)
references
References 9 publications
1
39
0
Order By: Relevance
“…Inhibition of the IP 3 -3K has been shown to elevate intracellular levels of IP 3 by halting its conversion into Ins(1,3,4,5)P4 [23]. Here, to examine the effects of IP 3 signaling on intracellular Zn 2+ dynamics, N 2 -(m-trifluorobenzyl),N 6 -(p-nitrobenzyl)purine, a membrane-permeable inhibitor of IP 3 -3K was employed to confirm the results observed using the caged IP 3 .…”
Section: Resultsmentioning
confidence: 99%
“…Inhibition of the IP 3 -3K has been shown to elevate intracellular levels of IP 3 by halting its conversion into Ins(1,3,4,5)P4 [23]. Here, to examine the effects of IP 3 signaling on intracellular Zn 2+ dynamics, N 2 -(m-trifluorobenzyl),N 6 -(p-nitrobenzyl)purine, a membrane-permeable inhibitor of IP 3 -3K was employed to confirm the results observed using the caged IP 3 .…”
Section: Resultsmentioning
confidence: 99%
“…Indeed, several groups have identified small-molecule ITPK inhibitors. Some show high ITPK-selectivity over IPMK33, 109112.…”
Section: Therapeutic Relevancementioning
confidence: 99%
“…Mast cells express ItpkB and produce IP 4 after stimulation115. Small-molecule ITPK-inhibition might augment their activation24, 109, but the target-selectivity of the low-affinity ITPK-inhibitors used is unknown and genetic studies are needed.…”
Section: Figures and Tablementioning
confidence: 99%
“…All ITPK inhibitors described so far interact with either the Ins(1,4,5)P 3 or ATP recognition sites in the catalytic domain [199][200][201]. Early attempts to identify inhibitory lead compounds employed exhaustive screens of inositol phosphate isomers [199,202].…”
Section: The Potential Of Itpk-based Therapiesmentioning
confidence: 99%
“…Screens of purine-based inhibitors acting at the ATP site have identified possible lead compounds for ITPK inhibition, but the likely problem here is lack of selectivity over other types of kinases, especially other members of the IPK family [203,204]. Indeed, a promising purinebased lead compound for ITPKA inhibition [200] was later shown to be a significantly more potent inhibitor of InsP 6 kinase [205]. The structural similarity of the ITPK ATPbinding site with an ancient kinase family emphasizes the difficulties of obtaining selectivity at the ATP site [23].…”
Section: The Potential Of Itpk-based Therapiesmentioning
confidence: 99%